down arrow

60 Degrees Pharmaceuticals, Inc.

  • Market Cap: N/A
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: US83006G1040
USD
0.98
-0.01 (-1.04%)

Dec 04

NAS

 Click here to see other stocks
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Comparison
Company
Score
Quality
Valuation
Financial
Technical
60 Degrees Pharmaceuticals, Inc.
Benitec Biopharma, Inc.
Kintara Therapeutics, Inc.
Lixte Biotechnology Holdings, Inc.
Exicure, Inc.
Revelation Biosciences, Inc.
Bio-Path Holdings, Inc.
ContraFect Corp.
PaxMedica, Inc.
Bon Natural Life Ltd.
Applied Molecular Transport, Inc.
Why is 60 Degrees Pharmaceuticals, Inc. ?
1
Poor Management Efficiency with a low ROE of 0%
  • The company has reported losses. Due to this company has reported negative ROE
2
Risky - Negative EBITDA
  • The stock is trading risky as compared to its average historical valuations
  • Over the past year, while the stock has generated a return of -82.39%, its profits have fallen by -29%
3
Below par performance in long term as well as near term
  • Along with generating -82.39% returns in the last 1 year, the stock has also underperformed S&P 500 in the last 3 years, 1 year and 3 months
stock-recommendationReal-Time Research Report
Verdict Report
How much should you sell?
  1. All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is 60 Degrees Pharmaceuticals, Inc. for you?

High Risk, Low Return

Absolute
Risk Adjusted
Volatility
60 Degrees Pharmaceuticals, Inc.
-81.85%
-0.24
397.99%
S&P 500
13.22%
0.61
20.17%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors
Factor
Value
Sales Growth (5y)
-87.20%
EBIT Growth (5y)
-148.80%
EBIT to Interest (avg)
100.00
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-0.80
Sales to Capital Employed (avg)
0.11
Tax Ratio
0
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
4.48%
ROCE (avg)
0
ROE (avg)
0
stock-recommendationValuation
Valuation Scorecard stock-summary
stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
1.05
EV to EBIT
-0.10
EV to EBITDA
-0.10
EV to Capital Employed
1.00
EV to Sales
1.00
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-1029.41%
ROE (Latest)
-248.09%
stock-recommendationTechnicals
Technical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Sideways
Bearish
Moving Averages
Bearish (Daily)
KST
Mildly Bullish
Dow Theory
No Trend
Mildly Bearish
OBV
No Trend
Mildly Bearish
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
Analyse All Technical Factors stock-recommendation
stock-recommendationFinancial Trend
Financial Trend Scorecard stock-summary
stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

21What is working for the Company
NET SALES(HY)

At USD 0.56 MM has Grown at 107.57%

OPERATING PROFIT(Q)

Highest at USD -1.59 MM

PRE-TAX PROFIT(Q)

Highest at USD -1.59 MM

NET PROFIT(Q)

Highest at USD -1.58 MM

RAW MATERIAL COST(Y)

Fallen by -198.16% (YoY

DEBTORS TURNOVER RATIO(HY)

Highest at 3.29 times

EPS(Q)

Highest at USD -1.25

-3What is not working for the Company
ROCE(HY)

Lowest at -285.78%

Here's what is working for 60 Degrees Pharmaceuticals, Inc.
Net Sales
At USD 0.56 MM has Grown at 107.57%
Year on Year (YoY)
MOJO Watch
Near term sales trend is very positive

Net Sales (USD MM)

Operating Profit
Highest at USD -1.59 MM and Grown
In each period in the last five periods
MOJO Watch
Near term Operating Profit trend is quite positive

Operating Profit (USD MM)

Pre-Tax Profit
Highest at USD -1.59 MM and Grown
In each period in the last five periods
MOJO Watch
Near term Pre-Tax Profit trend is very positive

Pre-Tax Profit (USD MM)

Net Profit
Highest at USD -1.58 MM and Grown
In each period in the last five periods
MOJO Watch
Near term Net Profit trend is very positive

Net Profit (USD MM)

Pre-Tax Profit
At USD -1.59 MM has Grown at 61.82%
Year on Year (YoY)
MOJO Watch
Near term Pre-Tax Profit trend is positive

Pre-Tax Profit (USD MM)

Net Profit
At USD -1.58 MM has Grown at 62.19%
Year on Year (YoY)
MOJO Watch
Near term Net Profit trend is positive

Net Profit (USD MM)

EPS
Highest at USD -1.25
in the last five periods
MOJO Watch
Increasing profitability; company has created higher earnings for shareholders

EPS (USD)

Debtors Turnover Ratio
Highest at 3.29 times
in the last five Semi-Annual periods
MOJO Watch
Company has been able to sell its Debtors faster

Debtors Turnover Ratio

Raw Material Cost
Fallen by -198.16% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther
Footer Logo
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
Market
Webinars
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."